Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWag Payment Regulatory News (WPS)

  • There is currently no data for WPS

Statement re Shareholder Engagement

26 Oct 2023 14:48

RNS Number : 4459R
Eurowag
26 October 2023

W.A.G payment solutions plc

(the "Company")

26 October 2023

In accordance with Provision 4 of the FRC's 2018 UK Corporate Governance Code, the Company has released this statement to provide an update to shareholders on the actions taken and the views received from shareholders, following the voting outcome of Resolution 13 at the Company's Annual General Meeting held on 11 May 2023 ("2023 AGM").

On 11 May 2023, the Company announced the results of the poll on the resolutions put before the 2023 AGM. The Company announced that over 20% of shareholders voting on Resolution 13 concerning the waiver of Rule 9, had voted against the resolution.

Resolution 13 was proposed as an ordinary resolution of the independent shareholders of the Company, which excludes shares held by the Concert Party (as defined in the Notice of AGM). The waiver of Rule 9 granted by Resolution 13 permits the Concert Party's interest in the Company's shares to increase as a result of the authority provided for in Resolution 17 to purchase the Company's own shares without requiring the Concert Party to make a mandatory offer for the other shareholders' shares.

Following an extensive analysis of the Company's Shareholder Register, the Company have established that the majority of the voting shares received against the waiver of Rule 9 are held in nominee accounts, many of which rely on shareholder advisory consultants to determine their voting. This means that underlying investors have been recommended to vote against share buybacks in principle as the shareholder advisory consultants are concerned about what they see as the Concert Party's potential creeping control of the Company. The Directors do not believe this is a valid concern for the Company or its shareholders.

The Company has been working to positively engage with the underlying shareholders and is accelerating its Investor Relations efforts in this regard and continue to do so. The Directors expect to continue to engage shareholders, including any dissenting shareholders in the coming months and to help resolve any concerns they may have. The outcome of this initiative will be published in the Company's Annual Report in spring 2024. In the meantime, the Board believe that the authorities provided by Resolution 17 and Resolution 13 are in the best interest of all shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
STRNKABQNBDDPKB
Date   Source Headline
17th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
15th Mar 20236:31 pmRNSCompletion of acquisition of Inelo
9th Mar 20232:27 pmRNSResult of General Meeting
3rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:09 amRNSAppointment of Chief Financial Officer
27th Feb 20234:35 pmRNSPrice Monitoring Extension
27th Feb 20237:00 amRNSAppointment of Joint Corporate Broker
20th Feb 20232:36 pmRNSPublication of Circular, Notice of General Meeting
19th Jan 20237:00 amRNSTrading Update
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSAcquisition of 30% of Sygic and update on Inelo
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
29th Nov 20224:40 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
1st Nov 20222:07 pmRNSDirector/PDMR Shareholding
25th Oct 20224:40 pmRNSSecond Price Monitoring Extn
25th Oct 20224:35 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSTrading Update and Board Changes
25th Oct 20227:00 amRNSEurowag to acquire Inelo
6th Oct 20224:35 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSEurowag to refinance existing debt
13th Sep 20228:00 amRNSAdmission to FTSE 250 Index
8th Sep 20225:30 pmRNSMeggitt - Update
6th Sep 20227:00 amRNSHalf-year Report
1st Jul 20227:00 amRNSEurowag completes the acquisition of WebEye assets
23rd Jun 20227:00 amRNSUpdate on completion of WebEye assets acquisition
26th May 20223:54 pmRNSResult of AGM
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:35 pmRNSPrice Monitoring Extension
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSUpdate on the acquisition of WebEye’s assets
5th May 20227:00 amRNSTrading Update
1st Apr 20227:54 amRNSAnnual Report and Notice of AGM
24th Mar 20227:00 amRNSPreliminary Results for year ended 31 Dec 2021
17th Mar 20229:57 amRNSChange of Registered Office
11th Mar 20225:58 pmRNSUpdate on the potential acquisition of WebEye
4th Mar 20229:44 amRNSNotice of Preliminary Results
17th Jan 20227:00 amRNSTrading Update
30th Dec 202112:25 pmRNSChange of Director Responsibilities
8th Dec 20214:37 pmRNSDirector/PDMR Shareholding
24th Nov 20219:42 amRNSDirector/PDMR Shareholding
16th Nov 20217:00 amRNSAppointment of Joint Corporate Brokers
15th Nov 20217:00 amRNSAcquisition of WebEye
11th Nov 20215:13 pmRNSStabilisation Notice
9th Nov 20213:15 pmRNSStabilisation Notice
8th Nov 20211:18 pmRNSStabilisation Notice
5th Nov 20211:18 pmRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.